Researchers discover nanobodies inhibit SARS-CoV-2 infection ANI | Updated: Apr 26, 2021 22:46 IST Melbourne [Australia], April 26 (ANI): In a groundbreaking discovery, Australian researchers have identified neutralising nanobodies that block the SARS-CoV-2 virus from entering cells in preclinical models. Published in PNAS, the research is part of a consortium-led effort, bringing together the expertise of Australian academic leaders in infectious diseases and antibody therapeutics at WEHI, the Doherty Institute and the Kirby Institute. At a glance -Researchers have identified nanobodies that effectively blocked the SARS-CoV-2 virus from entering cells in pre-clinical models of COVID-19 infection. -Nanobodies - which are tiny immune proteins - could provide an alternative to conventional antibody treatments for COVID-19.